The DOI matches its Crossref record.
Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis
Abstract
BACKGROUND: The management of recalcitrant chronic rhinosinusitis (CRS) is challenged by difficult-to- treat polymicrobial biofilms and multidrug resistant bacteria. This has led to the search for broad-spectrum non-antibiotic antimicrobial therapies. Colloidal silver (CS) has significant antibiofilm activity in vitro and in vivo against S. aureus, MRSA and P. aeruginosa. However, due to the lack of scientific efficacy, it is only currently used as an alternative medicine. This is the first study looking at the safety and efficacy of colloidal silver in recalcitrant CRS. METHODS: Patients were included when they had previously undergone endoscopic sinus surgery and presented with signs and symptoms of sinus infection with positive bacterial cultures. 22 patients completed the study. Patients were allocated to 10-14 days of culture- directed oral antibiotics with twice daily saline rinses (n=11) or 10 days of twice daily 0.015mg/mL colloidal silver rinses (n=11). Safety observations included pre- and post- treatment serum silver levels, University of Pennsylvania Smell Identification Test (UPSIT) and adverse event (AE) reporting. Efficacy was assessed comparing microbiology results, Lund Kennedy Scores (LKS) and symptom scores using Visual Analogue Scale (VAS) and Sino-Nasal Outcome Test (SNOT-22). RESULTS: CS demonstrated good safety profile with no major adverse events, no changes in UPSIT and transient serum silver level changes in 4 patients. CS patients had 1/11 (9.09%) negative cultures, compared to 2/11 (18.18%) in the control group upon completion of the study. Whilst not statistically significant, both groups showed similar improvement in symptoms and endoscopic scores. CONCLUSION: This study concludes that twice daily CS (0.015mg/mL) sinonasal rinses for 10 days is safe but not superior to culture-directed oral antibiotics. Further studies including more patients and looking at longer treatment or improving the tonicity of the solution for better tolerability should be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, when applied in clinical settings, colloidal silver and AgNps, delivered through sprays and nasal irrigation, did not exhibit the same level of efficacy [35,36].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 35
- 1996, Silver in Drinking Water: Background Document for the Development of WHO Guidelines for Drinking Water Quality
- Alandejani, 2009, Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms, Otolaryngol. Head Neck Surg., 141, 114, 10.1016/j.otohns.2009.01.005 · DOI · Paper page
- Bhol, 2005, Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis, Br. J. Dermatol., 152, 1235, 10.1111/j.1365-2133.2005.06575.x · DOI
- Chappell, 1954, Effect of silver ions on mitochondrial adenosine triphosphatase, Nature, 174, 930, 10.1038/174930b0 · doi:10.1038/174930b0
- Chiu, 2008, Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient, Am. J. Rhinol., 22, 34, 10.2500/ajr.2008.22.3122 · DOI · Paper page
- Dutsch-Wicherek, 2006, The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration, BMC Immunol., 7, 4, 10.1186/1471-2172-7-4 · doi:10.1186/1471-2172-7-4
- Eisenberg, 2008, [Increased expression and activity of MMP-9 in chronic rhinosinusitis with nasal polyposis], Acta Otorrinolaringol. Esp., 59, 444, 10.1016/S0001-6519(08)75116-1 · doi:10.1016/s0001-6519(08)75116-1
- Foreman, 2011, Do biofilms contribute to the initiation and recalcitrance of chronic rhinosinusitis?, Laryngoscope, 121, 1085, 10.1002/lary.21438 · DOI
- Fung, 1996, Silver products for medical indications: risk-benefit assessment, J. Toxicol. Clin. Toxicol., 34, 119, 10.3109/15563659609020246 · DOI · Paper page
- Goggin, 2014, Colloidal silver: a novel treatment for Staphylococcus aureus biofilms?, Int. Forum Allergy Rhinol., 4, 171, 10.1002/alr.21259 · DOI
- Jardeleza, 2011, The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis, Int. Forum Allergy Rhinol., 1, 438, 10.1002/alr.20083 · DOI
- Jervis-Bardy, 2012, A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis, Laryngoscope, 122, 2148, 10.1002/lary.23486 · DOI
- Jervis-Bardy, 2012, Microbiological outcomes following mupirocin nasal washes for symptomatic, Staphylococcus aureus-positive chronic rhinosinusitis following endoscopic sinus surgery, Int. Forum Allergy Rhinol., 2, 111, 10.1002/alr.20106 · DOI
- Kennedy, 2013, Sino-nasal outcome test (SNOT-22): a predictor of post-surgical improvement in patients with chronic sinusitis, Ann. Allergy Asthma Immunol., 111, 246, 10.1016/j.anai.2013.06.033 · DOI · Paper page
- Lansdown, 2006, Silver in health care: antimicrobial effects and safety in use, Curr. Probl. Dermatol., 33, 17, 10.1159/000093928 · DOI · Paper page
- Le, 2008, The efficacy of topical antibiofilm agents in a sheep model of rhinosinusitis, Am. J. Rhinol., 22, 560, 10.2500/ajr.2008.22.3232 · DOI
- Lund, 1995, Quantification for staging sinusitis. The Staging and Therapy Group, Ann. Otol. Rhinol. Laryngol. Suppl., 167, 17, 10.1177/000348949510410s02 · DOI · Paper page
- Modak, 1973, Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa, Biochem. Pharmacol, 22, 2391, 10.1016/0006-2952(73)90341-9 · DOI · Paper page
- Paramasivan, 2014, Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: safety and efficacy in an in vivo model, Int. Forum Allergy Rhinol., 4, 187, 10.1002/alr.21264 · DOI
- Rajiv, 2015, Topical colloidal silver as an anti-biofilm agent in a Staphylococcus aureus chronic rhinosinusitis sheep model, Int. Forum Allergy Rhinol., 5, 283, 10.1002/alr.21459 · DOI · Paper page
- Richter, Taking the silver bullet colloidal silver particles for the topical treatment of biofilm-related infections, ACS Appl. Mater. Interfaces, 9, 21631, 10.1021/acsami.7b03672 · DOI
- Richter, 2016, Mind “De GaPP”: in vitro efficacy of deferiprone and gallium-protoporphyrin against Staphylococcus aureus biofilms, Int. Forum Allergy Rhinol., 6, 737, 10.1002/alr.21735 · DOI
- Richter, A topical hydrogel with deferiprone and gallium-protoporphyrin targets bacterial iron metabolism and has antibiofilm activity, Antimicrob. Agents Chemother., 61, e00481, 10.1128/AAC.00481-17 · DOI
- Richter, Innovative approaches to treat Staphylococcus aureus biofilm-related infections, Essays Biochem., 61, 61, 10.1042/EBC20160056 · DOI
- Rosenkranz, 1972, Silver sulfadiazine: interaction with isolated deoxyribonucleic acid, Antimicrob. Agents Chemother., 2, 373, 10.1128/AAC.2.5.373 · doi:10.1128/aac.2.5.373
- Sauter, 2008, Regulation of matrix metalloproteinases (MMP)-2/-9 expression in eosinophilic chronic rhinosinusitis cell culture by interleukin-5 and−13?, In Vivo, 22, 415
- Schreurs, 1982, Effect of silver ions on transport and retention of phosphate by Escherichia coli, J. Bacteriol., 152, 7, 10.1128/jb.152.1.7-13.1982 · DOI · Paper page
- Seiberling, 2013, The effect of intraoperative mupirocin irrigation on Staphylococcus aureus within the maxillary sinus, Int. Forum Allergy Rhinol., 3, 94, 10.1002/alr.21076 · DOI
- Semeykina, 1990, Submicromolar Ag+ increases passive Na+ permeability and inhibits the respiration-supported formation of Na+ gradient in Bacillus FTU vesicles, FEBS Lett., 269, 69, 10.1016/0014-5793(90)81120-D · doi:10.1016/0014-5793(90)81120-d
- Solares, 2006, Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations, Am. J. Otolaryngol., 27, 161, 10.1016/j.amjoto.2005.09.006 · DOI
- Tomi, 2004, A silver man, Lancet, 363, 532, 10.1016/S0140-6736(04)15540-2 · doi:10.1016/s0140-6736(04)15540-2
- Uren, 2008, Nasal lavage with mupirocin for the treatment of surgically recalcitrant chronic rhinosinusitis, Laryngoscope, 118, 1677, 10.1097/MLG.0b013e31817aec47 · doi:10.1097/mlg.0b013e31817aec47
- Walker, 2000, Sinus symptom scores: what is the range in healthy individuals?, Clin. Otolaryngol. Allied Sci., 25, 482, 10.1046/j.1365-2273.2000.00349.x · doi:10.1046/j.1365-2273.2000.00349.x
- Wicherek, 2007, Analysis of metallothionein, RCAS1 immunoreactivity regarding immune cell concentration in the endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture, Gynecol. Obstet. Invest., 65, 52, 10.1159/000107649 · doi:10.1159/000107649
- Wright, 2002, Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing, Wound Repair Regen., 10, 141, 10.1046/j.1524-475X.2002.10308.x · DOI · Paper page
Cited by
Sim, W., Barnard, R. T., Blaskovich, M. A. T., & Ziora, Z. M. (2018) · Antibiotics · doi:10.3390/antibiotics7040093 · Cited by 370
Yathavan, B., Chhibber, T., Steinhauff, D., Pulsipher, A., Alt, J. A., Ghandehari, H., & Jafari, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102426 · Cited by 20
Metadata
- Authors
- Ooi, M. L., Richter, K., Bennett, C., Macias-Valle, L., Vreugde, S., Psaltis, A. J., & Wormald, P.-J.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-04-11
- Volume
- 9
- ISSN
- 1664-302X
- Cited by
- 25
- References
- 0
- Funders
- University of Adelaide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis. https://app.cochat.ai/papers/10.3389/fmicb.2018.00720
- The paper
- Ooi, M. L., Richter, K., Bennett, C., Macias-Valle, L., Vreugde, S., Psaltis, A. J., & Wormald, P.-J. (2018). Topical Colloidal Silver for the Treatment of Recalcitrant Chronic Rhinosinusitis. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2018.00720
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.